ubmslatePT-logo-ubm

PT Mobile Logo

Search form

Topics:

Kenneth J. Bender, PharmD, MA

Kenneth J. Bender, PharmD, MA

Posts by Author

Cardiovascular risk/benefit profiles of pioglitazone and the SGLT2 inhibitor class are summarized, based on reports at ADA 2017.

A1C vs FPG to diagnose prediabetes; prediabetes and CHF; and how much weight loss is too much? Reports from ADA 2017.

When to start screening for B12 deficiency in your diabetes patients taking metformin? We review a dose-response diet study plus 2 others on oral drugs.

Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.

"Ladies and gentlemen of the jury," began the PAINWeek 2016 speaker, in mock trial defense of a physician for over-prescribing opioid meds.

A PAINWeek 2016 expert panel gave attendees behind-the-scenes insight into the process behind the CDC's final recommendations.

At PAINWeek 2016, a session on abuse-deterrent formulations underscored that this drug class will never be free from abuse potential.

A PAINWeek audience experienced behavioral Rx during a presentation on effective non-drug treatment for migraine.

This PAINWeek 2016 presentation focused on how to more deeply involve patients in their own pain management plan.

A study of treatment tolerance and therapeutic response in children and adolescents with OCD.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.